When, where, and how to target vascular inflammation in the post-CANTOS era?-Reference-Cited by-同舟云学术

When, where, and how to target vascular inflammation in the post-CANTOS era?

Published:2019-03-30 Issue:30 Volume:40 Page:2492-2494
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Maffia Pasquale¹²³,Guzik Tomasz J¹⁴

Affiliation:

1. Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK

2. Centre for Immunobiology, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK

3. Department of Pharmacy, University of Naples Federico II, Naples, Italy

4. Department of Internal Medicine, Jagiellonian University, Collegium Medicum, Kraków, Poland

Abstract

Funder

Marie Sklodowska Curie CIG Award

European Research Council

British Heart Foundation

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/40/30/2492/29106541/ehz133.pdf

Reference19 articles.

1. Adaptive immunity in acute coronary syndromes: chicken or egg?;Libby;Eur Heart J,2018

2. Targeting inflammation to reduce cardiovascular disease risk: a realistic clinical prospect?;Welsh;Br J Pharmacol,2017

3. Antiinflammatory therapy with canakinumab for atherosclerotic disease;Ridker;N Engl J Med,2017

4. Low-dose methotrexate for the prevention of atherosclerotic events;Ridker;N Engl J Med,2019

5. Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial;Ridker;Lancet,2018

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunopharmacology sessions at the 19th World Congress of Basic & Clinical Pharmacology 2023;Pharmacological Research;2023-10

2. Inflammatory pathways in heart failure with preserved left ventricular ejection fraction: implications for future interventions;Cardiovascular Research;2022-08-25

3. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis;Cardiovascular Research;2021-12-02

4. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis;European Heart Journal;2021-11-16

5. Molecular imaging of cardiovascular inflammation;British Journal of Pharmacology;2021-10-14